Causes of death in men undergoing androg
โ
Anthony V. D'Amico; Ming-Hui Chen; Andrew A. Renshaw; Marian Loffredo; Philip W.
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 194 KB
## Abstract ## BACKGROUND. The authors estimated and characterized mortality after androgen suppression therapy (AST) use in men with newly diagnosed localized and recurrent prostate cancer. ## METHODS. The study cohorts comprised 102 men who were randomized to radiation therapy (RT) and AST and